Author： Dorota Torzecka Jolanta Narbutt Joanna Sysa-jedrzejowska Anna Borowiec Maciej Ptasinska Anetta Woszczek Grzegorz L. Kowalski Marek
Publisher： Informa Healthcare
ISSN： 1466-1861
Source： Mediators of Inflammation, Vol.12, Iss.5, 2003-10, pp. : 303-307
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tumour necrosis factor‐α antagonists as therapies for vitiligo
BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. :
Access to resources
Recommend
Tumour necrosis factor‐α antagonists as therapies for vitiligo
BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. :
Association of tumour necrosis factor‐α polymorphism in patients with end stage renal disease
NEPHROLOGY, Vol. 20, Iss. 6, 2015-06 ,pp. :
HZ risk associated with TNF‐α in RA
INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. :